Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Zoll Medical's defibrillator gets US clearance:

This article was originally published in Clinica

Executive Summary

Burlington, Massachusetts-based Zoll Medical has received US FDA 510(k) clearance for its Zoll M series defibrillator with end-tidal carbon dioxide (EtCO2) monitoring. The cardiac resuscitation device integrates a technology developed by Novametrix Medical Systems, called Capnostat, a solid-state sensor that monitors carbon dioxide and respiratory rate, pertinent to pacing and defibrillation. EtCO2 monitoring is the standard of care in hospital operating rooms, recovery areas, intensive care units and critical care units. The device can be used to assess patient airway integrity and proper endotracheal tube placement, the company said.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT075589

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel